Muhdo Health Expands Reach in Turkey Through Exclusive Partnership with Rgentic

Muhdo Health Expands Reach in Turkey Through Exclusive Partnership with Rgentic

Key Takeaways (TLDR)

• Muhdo Health gains a competitive edge in Turkey's genetic testing market through an exclusive distribution agreement with Rgentic.

• Muhdo Health partners with Rgentic to offer genetic testing kits in Turkey, with translated app and web portal for seamless customer experience.

• Muhdo Health's partnership with Rgentic in Turkey enhances access to genetic and epigenetic testing, promoting health, wellbeing, and longevity in the region.

• Muhdo Health's innovative approach to internal wellness through epigenetic profiling and personalized health programs revolutionizes preventive healthcare for a healthier future.

Why it Matters

This news matters as it signifies Muhdo Health's strategic move to penetrate the Turkish health market, offering advanced DNA and Epigenetic tests to a new audience. The partnership with Rgentic opens up opportunities for growth and establishes a strong foothold in Turkey's health and longevity sector.

Summary

Muhdo Health partners with Rgentic Saglik Turizm ve Ticaret AS to distribute genetic testing kits in Turkey, providing a localized experience through translated apps and portals. The exclusive agreement includes the launch of a Turkish-language Muhdo website.

This news story relied on a press release distributed by BlockchainWire. Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is Muhdo Health Expands Reach in Turkey Through Exclusive Partnership with Rgentic.